Instil Bio, Inc. Common Stock
TIL Real Time Price USDRecent trades of TIL by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by TIL's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Cells expressing recombinant growth factor receptors Oct. 15, 2024
-
Patent Title: Receptors providing targeted costimulation for adoptive cell therapy Apr. 02, 2024
-
Patent Title: Devices and methods for isolating tumor infiltrating lymphocytes and uses thereof Sep. 26, 2023
-
Patent Title: Chimeric molecules providing targeted costimulation for adoptive cell therapy Jul. 11, 2023
-
Patent Title: Aseptic tissue processing method, kit and device Apr. 04, 2023
-
Patent Title: Aseptic tissue processing method, kit and device Apr. 04, 2023
-
Patent Title: Cells expressing recombinant growth factor receptors Dec. 20, 2022
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of TIL in WallStreetBets Daily Discussion
Recent insights relating to TIL
Recent picks made for TIL stock on CNBC
ETFs with the largest estimated holdings in TIL
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view TIL Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.